Cempra Pharmaceuticals, Inc.
Part of Melinta Therapeutics, LLC
Company facts
- FY2025 rankings
-
Its parent company, Melinta Therapeutics, LLC, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Parsippany-Troy Hills, NJ
H8K6F2A4KD49
-
Parent
Parsippany-Troy Hills, NJ
H8K6F2A4KD49
- SAM.gov registration date
- Website
- melinta.com
- Founded
- 2000
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cempra - solithromycin (CEM-101) for civilian use and broad bioterror threat medical countermeasures. | Office of the Assistant Secretary for Preparedness and Response | $52,487,981 |
Quick answers
Is Cempra Pharmaceuticals, Inc. registered in SAM.gov?
Cempra Pharmaceuticals, Inc.'s SAM.gov registration expired on June 10, 2020.
What is Cempra Pharmaceuticals, Inc.'s CAGE code?
Cempra Pharmaceuticals, Inc.'s CAGE code is 4D2L7, and its Unique Entity ID (UEI) is ELLHEBHB4ZQ7.
How does Cempra Pharmaceuticals, Inc. rank among federal contractors?
Cempra Pharmaceuticals, Inc.'s parent company, Melinta Therapeutics, LLC, ranked #19 in NAICS 541714 and #33 in PSC AN in FY2025.
What is Cempra Pharmaceuticals, Inc.'s most recent federal award?
Cempra Pharmaceuticals, Inc.'s most recent federal contract award is Cempra - solithromycin (CEM-101) for civilian use and broad bioterror threat medical countermeasures (HHSO100201300009C), from Office of the Assistant Secretary for Preparedness and Response, on May 24, 2013.
On GovTribe
See Cempra Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors